GIORDANO, CINZIA
 Distribuzione geografica
Continente #
EU - Europa 36
AS - Asia 32
NA - Nord America 15
AF - Africa 1
Totale 84
Nazione #
SG - Singapore 28
DE - Germania 17
US - Stati Uniti d'America 14
FI - Finlandia 8
IT - Italia 5
HK - Hong Kong 2
NL - Olanda 2
AE - Emirati Arabi Uniti 1
CA - Canada 1
CZ - Repubblica Ceca 1
ES - Italia 1
GB - Regno Unito 1
KE - Kenya 1
SE - Svezia 1
VN - Vietnam 1
Totale 84
Città #
Singapore 16
Munich 14
Turku 8
Ashburn 3
Nuremberg 3
Carney 2
Hong Kong 2
Boston 1
Brooklyn 1
Haiphong 1
Montreal 1
Nairobi 1
Naples 1
Olomouc 1
San Francisco 1
Seattle 1
Stockholm 1
The Dalles 1
Totale 59
Nome #
Evidence that CRISPR-Cas9 Y537S-mutant expressing breast cancer cells activate Yes-associated protein 1 to driving the conversion of normal fibroblasts into cancer-associated fibroblasts 13
Novel insights into the antagonistic effects of losartan against angiotensin ii/agtr1 signaling in glioblastoma cells 11
Mutations in the estrogen receptor alpha hormone binding domain promote stem cell phenotype through notch activation in breast cancer cell lines 11
Phosphodiesterase 5 (PDE5) Expression and Function in Breast Cancer Stroma: an Attractive Opportunity for Targeted Therapy 11
Leptin Modulates Exosome Biogenesis in Breast Cancer Cells: an Additional Mechanism in Cell-to-Cell Communication 11
Adipocyte-derived extracellular vesicles promote breast cancer cell malignancy through HIF-1α activity 11
Role of Phosphodiesterase 5 (PDE5) in Breast Cancer Stroma: Implications for Targeted Therapy 9
Phosphodiesterase 5 (PDE5) is highly expressed in cancer-associated fibroblasts and enhances breast tumor progression 9
Tamoxifen through GPER upregulates aromatase expression: a novel mechanism sustaining tamoxifen-resistant breast cancer cell growth 8
Totale 94
Categoria #
all - tutte 1.124
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.124


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/202585 0 0 0 0 0 16 15 3 4 0 12 35
2025/20269 9 0 0 0 0 0 0 0 0 0 0 0
Totale 94